These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 22836016)

  • 21. Altered balance of proteolytic isoforms of pro-brain-derived neurotrophic factor in autism.
    Garcia KL; Yu G; Nicolini C; Michalski B; Garzon DJ; Chiu VS; Tongiorgi E; Szatmari P; Fahnestock M
    J Neuropathol Exp Neurol; 2012 Apr; 71(4):289-97. PubMed ID: 22437340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. No association of the Val66Met polymorphism of brain-derived neurotrophic factor (BDNF) to multiple sclerosis.
    Blanco Y; Gómez-Choco M; Arostegui JL; Casanova B; Martínez-Rodríguez JE; Boscá I; Munteis E; Yagüe J; Graus F; Saiz A
    Neurosci Lett; 2006 Apr; 396(3):217-9. PubMed ID: 16356643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The antidepressive effect of the physical exercise correlates with increased levels of mature BDNF, and proBDNF proteolytic cleavage-related genes, p11 and tPA.
    Sartori CR; Vieira AS; Ferrari EM; Langone F; Tongiorgi E; Parada CA
    Neuroscience; 2011 Apr; 180():9-18. PubMed ID: 21371535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Age-related changes in brain-derived neurotrophic factor and tyrosine kinase receptor isoforms in the hippocampus and hypothalamus in male rats.
    Silhol M; Bonnichon V; Rage F; Tapia-Arancibia L
    Neuroscience; 2005; 132(3):613-24. PubMed ID: 15837123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of autoimmune demyelination by laquinimod via induction of brain-derived neurotrophic factor.
    Thöne J; Ellrichmann G; Seubert S; Peruga I; Lee DH; Conrad R; Hayardeny L; Comi G; Wiese S; Linker RA; Gold R
    Am J Pathol; 2012 Jan; 180(1):267-74. PubMed ID: 22152994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dysregulated neurotrophin mRNA production by immune cells of patients with relapsing remitting multiple sclerosis.
    Urshansky N; Mausner-Fainberg K; Auriel E; Regev K; Farhum F; Karni A
    J Neurol Sci; 2010 Aug; 295(1-2):31-7. PubMed ID: 20541775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum brain-derived neurotrophic factor levels in patients with major depression: effects of antidepressants.
    Huang TL; Lee CT; Liu YL
    J Psychiatr Res; 2008 Jun; 42(7):521-5. PubMed ID: 17585940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of combined exercise training on serum brain-derived neurotrophic factor, suppressors of cytokine signaling 1 and 3 in patients with multiple sclerosis.
    Ozkul C; Guclu-Gunduz A; Irkec C; Fidan I; Aydin Y; Ozkan T; Yazici G
    J Neuroimmunol; 2018 Mar; 316():121-129. PubMed ID: 29329698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurotrophic factors in relapsing remitting and secondary progressive multiple sclerosis patients during interferon beta therapy.
    Caggiula M; Batocchi AP; Frisullo G; Angelucci F; Patanella AK; Sancricca C; Nociti V; Tonali PA; Mirabella M
    Clin Immunol; 2006 Jan; 118(1):77-82. PubMed ID: 16275091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced production of noggin by immune cells of patients with relapsing-remitting multiple sclerosis.
    Urshansky N; Mausner-Fainberg K; Auriel E; Regev K; Bornstein NM; Karni A
    J Neuroimmunol; 2011 Mar; 232(1-2):171-8. PubMed ID: 21111488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolution of brain-derived neurotrophic factor levels after autologous hematopietic stem cell transplantation in multiple sclerosis.
    Blanco Y; Saiz A; Costa M; Torres-Peraza JF; Carreras E; Alberch J; Jaraquemada D; Graus F
    Neurosci Lett; 2005 May 20-27; 380(1-2):122-6. PubMed ID: 15854763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of glatiramer acetate on paraclinical markers of neuroprotection in multiple sclerosis: A prospective observational clinical trial.
    Ehling R; Di Pauli F; Lackner P; Rainer C; Kraus V; Hegen H; Lutterotti A; Kuenz B; De Zordo T; Schocke M; Glatzl S; Löscher WN; Deisenhammer F; Reindl M; Berger T
    J Neuroimmunol; 2015 Oct; 287():98-105. PubMed ID: 26439969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BDNF and Tau as biomarkers of severity in multiple sclerosis.
    Islas-Hernandez A; Aguilar-Talamantes HS; Bertado-Cortes B; Mejia-delCastillo GJ; Carrera-Pineda R; Cuevas-Garcia CF; Garcia-delaTorre P
    Biomark Med; 2018 Jul; 12(7):717-726. PubMed ID: 29865854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of Fas antigen on T cell subpopulations in peripheral blood of patients with relapsing-remitting multiple sclerosis.
    Bilińska M; Frydecka I; Podemski R; Teodorowska R; Gruszka E
    Med Sci Monit; 2001; 7(2):251-5. PubMed ID: 11257731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain-derived neurotrophic factor (BDNF) and set-shifting in currently ill and recovered anorexia nervosa (AN) patients.
    Nakazato M; Tchanturia K; Schmidt U; Campbell IC; Treasure J; Collier DA; Hashimoto K; Iyo M
    Psychol Med; 2009 Jun; 39(6):1029-35. PubMed ID: 18752728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain derived neurotrophic factor in multiple sclerosis: effect of 24 weeks endurance and resistance training.
    Wens I; Keytsman C; Deckx N; Cools N; Dalgas U; Eijnde BO
    Eur J Neurol; 2016 Jun; 23(6):1028-35. PubMed ID: 26992038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brain-derived neurotrophic factor is increased in serum and skin levels of patients with chronic spontaneous urticaria.
    Rössing K; Novak N; Mommert S; Pfab F; Gehring M; Wedi B; Kapp A; Raap U
    Clin Exp Allergy; 2011 Oct; 41(10):1392-9. PubMed ID: 21676041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma brain-derived neurotrophic factor (BDNF) and sphingosine-1-phosphat (S1P) are NOT the main mediators of neuroprotection induced by resistance training in persons with multiple sclerosis-A randomized controlled trial.
    Jørgensen MLK; Kjølhede T; Dalgas U; Hvid LG
    Mult Scler Relat Disord; 2019 Jun; 31():106-111. PubMed ID: 30965275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects.
    Dwivedi Y; Rizavi HS; Conley RR; Roberts RC; Tamminga CA; Pandey GN
    Arch Gen Psychiatry; 2003 Aug; 60(8):804-15. PubMed ID: 12912764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interferon-beta therapy up-regulates BDNF secretion from PBMCs of MS patients through a CD40-dependent mechanism.
    Azoulay D; Mausner-Fainberg K; Urshansky N; Fahoum F; Karni A
    J Neuroimmunol; 2009 Jun; 211(1-2):114-9. PubMed ID: 19419774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.